37
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Concentrations of Pentosidine, an Advanced Glycation End-product, in Umbilical Cord Blood

, , , , , , , & show all
Pages 691-695 | Received 16 Mar 2004, Published online: 07 Jul 2009

References

  • Taniguchi, N., Kaneto, H., Asahi, M., Takahashi, M., Wenyi, C., Higashiyama, S., Fujii, J., Suzuki, K. and Kayanoki, Y. (1996) "Involvement of glycation and oxidative stress in diabetic macroangiopathy", Diabetes 45\(Suppl. 3), S81–S83.
  • Miyata, T., Kurokawa, K. and van Ypersele de Strihou, C. (2000) "Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism", J. Am. Soc. Nephrol. 11, 1744–1752.
  • Wolff, S.P. and Dean, R.T. (1987) "Glucose autoxidation and protein modification: the potential role of 'autoxidative glycosylation' in diabetes", Biochem. J. 245, 243–250.
  • Dyer, D.C., Blackledge, J.A., Thorpe, S.R. and Baynes, J.W. (1991) "Formation of pentosidine during nonenzymatic browning of proteins by glucose: identification of glucose and other carbohydrates as possible precursors of pentosi-dine in vivo", J. Biol. Chem. 266, 11654–11660.
  • Makita, Z., Bucala, R., Rayfield, E.J., Friedman, E.A., Kaufman, A.M., Korbet, S.M., Barth, R.H., Winston, J.A., Fuh, H., Manogue, K.R., Cerami, A. and Vlassara, H. (1994) "Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure", Lancet 343, 1519–1522.
  • Witko-Sarsat, V, Friedlander, M., Capeillere-Blandin, C., Nguyen-Khoa, T., Nguyen, A.T., Zingraff, J., Jungers, P. and Descamps-Latscha, B. (1996) "Advanced oxidation protein products as a novel marker of oxidative stress in uremia", Kidney Int. 49, 1304–1313.
  • Miyata, T., Wada, Y, Cai, Z., Iida, Y., Hone, K., Yasuda, Y., Maeda, K., Kurokawa, K. and van Ypersele de Strihou, C. (1997) "Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure", Kidney Int. 51, 1170–1181.
  • Miyata, T., Ishiguro, N., Yasuda, Y., Ito, T., Nangaku, M., Iwata, H. and Kurokawa, K. (1998) "Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers", Biochem. Biophys. Res. Commun. 244, 45–49.
  • Miyata, T., Inagi, R., Asahi, K., Yamada, Y., Hone, K., Sakai, H., Uchida, K. and Kurokawa, K. (1998) "Generation of protein carbonyls by glycoxidation and lipmddation reactions with autmddation products of ascorbic acid and polyunsaturated fatty acids", FEBS Lett. 437, 24–28.
  • Sugiyama, S., Miyata, T., Ueda, Y., Tanaka, H., Maeda, K., Kawashima, S., van Ypersele de Strihou, C. and Kurokawa, K. (1998) "Plasma levels of pentosidine in diabetic patients: an advanced glycation end product", J. Am. Soc. Nephrol. 9, 1681–1688.
  • Castellani, R.J., Harris, P.L.R, Sayre, L.M., Fujii, J., Taniguchi, N., Vitek, M.P., Founds, H., Atwood, CS., Perry, G. and Smith, M.A. (2001) "Active glycation in neurofibrillary pathology of Alzheimer disease: N'-(carboxymethyl)lysine and hexitol-lysine", Free Radic. Biol. Med. 31, 175–180.
  • Tsukahara, H., Sekine, K., Uchiyama, M., Kawakami, H., Hata, I., Todoroki, Y., Hiraoka, M., Kaji, M., Yorifuji, T., Momoi, T., Yoshihara, K., Beppu, M. and Mayumi, M. (2003) "Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes", Pediatr. Res. 54, 419–424.
  • Yamamoto, T., Shibata, N., Muramatsu, F., Sakayori, N. and Kobayashi, M. (2002) "Oxidative stress in the human fetal brain: an immunohistochemical study", Pediatr. Neurol. 26, 116–122.
  • Yoshihara, K., Nakamura, K., Kanai, M., Nagayama, Y., Takahashi, S., Saito, N. and Nagata, M. (1998) "Determination of urinary and serum pentosidine and its application to elder patients", Biol. Pharm. Bull. 21, 1005–1008.
  • Dyer, D.C., Dunn, J.A., Thorpe, SR., Bailie, K.E., Lyons, T.J., McCance, D.R. and Baynes, J.W. (1993) "Accumulation of Maillard reaction products in skin collagen in diabetes and aging", J. Clin. Investig. 91, 2463–2469.
  • Malik, N.S., Moss, S.J., Ahmed, N., Furth, A.J., Wall, R.S. and Meek, K.M. (1992) "Ageing of the human corneal stroma: structural and biochemical changes", Biochim. Biophys. Acta 1138, 222–228.
  • Sato, Y, Kondo, T. and Ohshima, T. (2001) "Estimation of age of human cadavers by immunohistochemical assessment of advanced glycation end products in the hippocampus", Histopathology 38, 217–220.
  • Verzijl, N., DeGroot, J., Bank, R.A., Bayliss, M.T., Bijlsma, J.W.J., Lafeber, F.P.J.G., Maroudas, A. and TeKoppele, J.M. (2001) "Age-related accumulation of the advanced glycation endproduct pentosidine in human articular cartilage aggre-can: the use of pentosidine levels as a quantitative measure of protein turnover", Matrix Biol. 20, 409–417.
  • Toyokuni, S. (1999) "Reactive oxygen species-induced molecular damage and its application in pathology", Pathol. Int. 49, 91–102.
  • Chappell, L.C., Seed, P.T., Kelly, F.J., Briley, A., Hunt, B.J., Charnock-Jones, D.S., Mallet, A. and Poston, L. (2002) "Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function", Am. J. Obstet. Gynecol. 187, 777–784.
  • Madazli, R., Benian, A., Aydin, S., Uzun, H. and Tolun, N. (2002) "The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia", J. Obstet. Gynaecol. 22, 477–480.
  • Roberts, J.M. and Lain, K.Y. (2002) "Recent insights into the pathogenesis of pre-eclampsia", Placenta 23, 359–372.
  • Wijnberger, L.D.E., Krediet, T.G., Visser, G.H.A., van Bel, F. and Egberts, J. (2003) "Early neonatal antioxidant capacity after preexisting impaired placental function", Early Hum. Dev. 71, 111–116.
  • Maulik, D., Numagami, Y., Ohnishi, ST., Mishra, O.P. and Delivoria-Papadopoulos, M. (1998) "Direct measurement of oxygen free radicals during in utero hypoxia in the fetal guinea pig brain", Brain Res. 798, 166–172.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.